Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares $ Sukuk UCITS ETF
SKUK · IE000929U2U9 · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · Emerging marketsSFDR art. 6
Index tracked: J.P. Morgan EM Aggregate Sukuk Index
- TER
- 0.40%+ trans. 0.02%
- Fund size
- 159 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (optimised)
- Income
- Distributingsemi-annual
- Duration
- 4.05 yrsmedium (3–7 years)
Launch 17 Jan 2024 · costs from the KID as of 2 Sept 2026 · 220 securities held · 5 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Share Class aims to achieve a total return, taking into account both capital and income returns, which reflects the return of the J.P. Morgan EM Aggregate Sukuk Index the Fund’s benchmark index (Index). The Share Class, via the Fund, is passively managed and aims to invest so far as possible, and in a manner consistent with Shari’ah principles, in the Sukuk instruments that make up the Index. The Index measures the performance of US Dollar denominated emerging market Sukuk instruments issued by sovereign, quasi-sovereign, corporate and supranational…
Performance since series start (in euro) — base 100
17 Jan 2024 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +3.0% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +6.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 3.94% | 3.94% | — |
| Max drawdown | −5.12% | −5.12% | — |
| Sharpe | -1.59 | -1.59 | — |
| Sortino | -1.76 | -1.76 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SKUK · IE000929U2U91
RebalixSKUK · IE000929U2U9 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +7.37% | +7.74% | −0.38% |
Fixed income — as declared by the issuer
Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): 75.0%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.30 USD (5.99% of NAV) · last ex-date 20 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.18 | — |
| 2025 | 2 | 0.25 | +4.95% |
| 2024 | 2 | 0.20 | — |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 220 securities · top-10 weight = 11.6%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
5W00 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 16 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000929U2U9
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000929U2U9
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · SKUK · IE000929U2U92